Guillain–Barré Syndrome Variant Occurring after SARS-CoV-2 Vaccination

U.K, 30 May 2021, Allen et al, Annals of Neurology


Report of 4 cases of bifacial weakness with paresthesias variant Guillaine Barre’ syndrome occurring after administration of the first dose of AZV, all cases having presented within 10 days of each other. Symptom onset occurred 11 to 22 days post-vaccination.

Download PDF

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s